| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485841 | Vaccine | 2018 | 8 Pages |
Abstract
These data show that hVEGF26-104/RFASE can be safely administered in cynomolgus monkeys, induces the desired immune response and therefore support the clinical development of this vaccine.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Madelon Q. Wentink, Henk M.W. Verheul, Arjan W. Griffioen, Kenneth A. Schafer, Susan McPherson, Richard J. Early, Hans J. van der Vliet, Tanja D. de Gruijl,